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.2012.05.Abstract Purpose: To compare possible unlabeled effect of ephedrine, as shivering prophylaxis,
with meperidine during spinal anesthesia for Cesarean Section.
Methods: After institutional ethical committee approval, 96 parturients scheduled for elective
cesarean delivery under spinal anesthesia were randomly allocated according to shivering prophy-
laxis to receive either 15 mg meperidine (group M, n= 48) or 6 mg ephedrine (group E, n= 48)
intravenously before spinal block. Incidence and intensity of shivering as well as side effects of
either drug were assessed.
Results: The incidence shivering in meperidine and ephedrine groups in women undergoing Cesar-
ean Section under spinal anesthesia was comparable (27%, 29% respectively, P= 0.06). Also,
intensity of shivering was not different between two groups. Moreover, phenylephrine requirement
and incidence of nausea and vomiting were signiﬁcantly less in ephedrine group (121 ± 2.2% and
4.1% respectively) relative to meperidine group (168 ± 3.2% and 16.6% respectively).
Conclusion: The prophylactic use of a low dose ephedrine is effective as meperidine for shivering
prophylaxis in women undergoing Cesarean Section under spinal anesthesia as meperidine. More-
over, it is associated with less hypotension, nausea and vomiting.
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0011. Introduction
Shivering, rhythmic oscillatory movement of upper limbs, neck
and jaw, is common during regional anesthesia with an inci-
dence up to 56.7% of patients [1,2]. Increase of oxygen con-
sumption, CO2 production, and interference with monitoring
of blood pressure and ECG, and general discomfort are the
main squeals of shivering [3]. Those effects are particularly
bothering in the obstetrical population [4]. Ephedrine, aosting by Elsevier B.V. Open access under CC BY-NC-ND license.
238 A. El-Deeb, R. Barakatwell-known sympathomimetic agent, has been used to treat
hypotension during regional anesthesia. It has antiemetic effect
for short-term [5]. Ephedrine maintained hemodynamics and
minimized decrease of the core temperature when given by
an intravenous infusion during spine surgery under general
anesthesia [6].
Although, meperidine is the best studied drug in the treat-
ment of post-anesthetic shivering, other drugs, like Ondanse-
tron, hydrocortisone, tramadol hydrochloride and
nalbuphine were used [7–9]. Side effects of IV meperidine like
nausea, vomiting, pruritus, hypotension, bronchospasm, bra-
dycardia, and respiratory insufﬁciency are reported to be
dose-related [10].
The primary concern of this study is to compare effect of a
preemptive low dose ephedrine, commonly used during spinal
anesthesia for CS, for shivering prophylaxis in women under-
going cesarean delivery under regional anesthesia in compari-
son with meperidine. Secondary outcome measures were side
effects and patients satisfaction.2. Patient and methods
After institutional ethical committee approval and written in-
formed consent from the parturients, this study was performed
in 96 women ASA I and II (American Society of Anesthesiol-
ogists), with uncomplicated pregnancies, who were scheduled
for elective cesarean delivery under spinal anesthesia.
Exclusion criteria included refusal or contraindications to
regional anesthesia or obesity, diabetes or thyroid disease. All
parturients received 15 ml/kg IV lactated Ringer’s solution over
30 min before spinal injection. The operative room temperature
was kept at 21 C. The parturients were randomly divided into
two groups according to shivering prophylaxis using a com-
puter-generated code. The group M (n= 48) received i.v.
15 mg meperidine, while group E (n= 48) received i.v. 6 mg
ephedrine. Both drugs solutions looked identical, were pre-
pared in 2 ml saline by pharmacist unaware of the randomiza-
tion code and were given by an assistant, who was blinded to
group assignment, just before spinal anesthesia. After place-
ment of standard monitors, spinal anesthesia with 0.5% hyper-
baric bupivacaine according to height (2.6 ml for patients taller
than 155 cm and 2.4 ml for those shorter than 155 cm) was
administered. After induction of spinal anesthesia, the parturi-
ent was placed supine with left uterine displacement and head
up with slight trendlenberg of the table to achieve adequate sur-
gical block (T4 sensory level) which was assessed by analgesia
to pinprick with ﬁne dental needle. Non-invasive arterial blood
pressure was measured every 5 min until the end of surgery.
Supplementary oxygen 3 l/min was administered. Shell temper-
ature was monitored continuously during surgery by means of
axillary probe and was reported at 10 min interval. Surface skin
warming was achieved by adequate wrapping of the skin.
Maternal hypotension (decrease in systolic blood pressure of
>10% from baseline) after spinal anesthesia was treated
aggressively with additional IV ﬂuid, more uterine tilt, and
increments of IV phenylephrine 25 lg. After delivery of the
baby, 5 U of IV oxytocin was given to all parturient to enhance
uterine contraction. Intensity of shivering was assessed using a
ﬁve-point scale: Grade 0: No shivering; Grade 1: one or more
areas of piloerection but without visible muscular activity;
Grade 2: visible muscular activity conﬁned to one musclegroup; Grade 3: same as Grade 2 but in more than one muscle
group; and Grade 4: gross muscular activity involving the entire
body [11]. Shivering was assessed at every 5 min for 1 h after
spinal anesthesia then at 80 and 90 min later.
An ant shivering ‘‘rescue’’ drug (4 mg ondansetron intrave-
nously) was administered in case of need for shivering treat-
ment within the study period.
Data were also collected regarding time the durations of sur-
gery, amount of phenylephrine consumed and complications
(nausea, vomiting, pruritus, respiratory depression and allergic
reactions). Patient satisfaction with shivering prophylaxis was
evaluated and recorded (11-point verbal numeric scoring sys-
tem, 0 = not at all satisﬁed, 10 = fully satisﬁed). Sedation
was assessed with modiﬁed Ramsey sedation score (RSS) [12]
(Awake levels were: 1, patient anxious and agitated or restless
or both; 2, patient co-operative, orientated, and tranquil; 3, pa-
tient responds to commands only. Asleep levels were dependent
on the patient’s response to a light glabellar tap or loud audi-
tory stimulus: Level 4, a brisk response; 5, a sluggish response;
and 6, no response) 20 min after spinal block.
3. Statistical analysis
The statistical analysis of data was done by using excel pro-
gram and SPSS program (statistical package for social science)
version 11 (SPSS Inc., Chicago, IL, USA). K–S (Kolmogorov–
Smirnov) test was done to test the normality of quantitative
data. The analysis of the data was done using Student’s un-
paired t-test. Scores for pain and sedation were analyzed using
the Mann–Whitney U-test. Data were expressed as
mean ± standard deviation or frequency (%), or medians
(ranges). P is signiﬁcant if <0.05 at conﬁdence interval 95%.
Sample size was determined by using Epicalc program 2000
at power 80% and conﬁdence interval 95% assuming that
the highest shivering intensity score was 85% [4]. To ﬁnd a
50% reduction of that value, a sample size of 40 patients per
group was necessary. Extra numbers were taken to avoid
defaulters, so each group = 50.
4. Results
One hundred and three parturients were assessed for eligibility.
Three patients were excluded; two with hepatic insufﬁciency
and one with localized infection at site of spinal anesthesia.
One hundred parturients were randomized into two equal
groups. Two cases were excluded in either group (Figure 1).
The two groups were not signiﬁcantly different with respect
to demographic characteristics (Table 1). The two groups were
statistically comparable as regard to heart rate and mean arte-
rial blood pressure (Figures 2 and 3).
The two groups showed no difference regarding level of
sensory block, duration of surgery and sedation score. How-
ever, total dose of phenylephrine was signiﬁcantly less in group
E. Number of patients who experienced shivering or requiring
additional anti-shivering rescue was comparable in both
groups. Also, intraoperative temperature of both groups were
comparable at different time points (Table 2). Grading of shiv-
ering showed no statistically signiﬁcant difference between two
groups (Figure 4). Nausea and vomiting were statistically sig-
niﬁcant less in group E when compared to group M. Satisfac-
tion score was comparable in both groups (Table 3).
Assessed for eligibility (n=103)
Excluded (n= 3)
Hepatic insufficiency (n=2 )
  Localised infection (n=1)
Randomized (n=100)
Meperidine  group (group M) 
n = 50
Ephedrine group (group E)    
           n =50
Discontinued n = 2
ailed spinal
Discontinued n = 2
Failed spinal
Analyzed n = 48 Analyzed n = 48
Figure 1 Study ﬂowchart.
Figure 2 Intraoperative heart rate changes (beat/min).
Table 1 Demographic data of patients.
Variable M group
(n= 48)
E group
(n= 48)
P value
Age (yr) 28.5 ± 2.4 27.8 ± 4.3 0.43
Weight (kg) 81 ± 2.4 79 ± 3.2 0.51
Height (cm) 168.2 ± 3.4 168.3 ± 3.3 0.42
Gestational age (weeks) 38.6 ± 1.4 38.7 ± 3.1 0.5
M; meperidine, E; ephedrine. Data are presented as mean ± stan-
dard deviation.
\P< 0.05 signiﬁcant compared with group M.
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This study showed that use a small dose of ephedrine, as shiv-
ering prophylaxis in women undergoing Cesarean Sec-
tion under spinal anesthesia, resulted in similar incidence
(29% compared to 27%, P= 0.06) and intensity of shivering
as meperidine Furthermore, it is associated with less hypoten-
sion, as evidenced by less phenylephrine requirement
(121 ± 2.2 versus 168 ± 3.2, P value = 0.04), nausea andvomiting (16.6 versus 4.1%, P value = 0.03) and comparable
satisfaction with shivering prophylaxis.
Meperidine has been given by intrathecal route to reduce
the incidence and severity of shivering during spinal anesthesia
for CS [4]. Intravenous meperidine, in a dose of 25 mg, is the
gold standard for the treatment of post-anesthetic shivering
as it can stop it within 5 min [13,14]. The use IV meperidine
Figure 3 Intraoperative mean blood pressure changes (mm Hg).
Figure 4 Intensity of shivering.
Table 3 Patient satisfaction and side effects.
Variable M group
(n= 48)
E group
(n= 48)
P value
Patient satisfaction score 8.6 ± 1.2 8.7 ± 13 0.4
Nausea and vomiting (%) 8 (16.6%) 2 (4.1%)* 0.03
Pruritus (%) 1 (2%) 1 (2%) 0.13
Respiratory depression (%) 0 0
Data are presented as mean ± standard deviation or number (%).
* P< 0.05 signiﬁcant compared with group M.
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ative experience associated with shivering and resulted in less
side effects associated with meperidine [4]. Anti-shivering of
meperidine is mediated by j-receptor agonist activity [15,16].
Ephedrine, a well-known sympathomimetic agent, is fre-
quently used for treatment of hypotension especially during
CS under spinal anesthesia [17]. Ephedrine has been reported
to have antiemetic effects during laparoscopic cholecystec-
tomy, abdominal hysterectomy and gynecologic laparoscopy
[18–21]. The exact mechanism of unlabeled shivering prophy-
laxis achieved by low dose ephedrine under spinal anesthesia
is unknown. It could be explained by vasoconstriction of skel-
etal muscle vessels which could counteract loss of thermoregu-
latory vasoconstriction below the level of spinal blockade.
Ephedrine has been investigated to minimize the decrease of
the core temperature during spine surgery under general anes-
thesia. Jo et al. [6] concluded that maintenance of the core tem-
perature by ephedrine is primarily due to enhancing the
sympathetic neuronal release of norepinephrine and epineph-
rine, which is mediated through beta-adrenoreceptors stimula-
tion. Correlation between core and surface temperatures
during shivering prophylaxis with ephedrine or meperidine
has been extensively discussed [6,7,22,23] so it is not investi-
gated in this study. In this study, we use a fairly low dose of
either drug to avoid complications.Table 2 Intraoperative data.
Variable M group (n= 48)
Sensory block (median, range) T4 (T2–T6)
Surgery duration (min) 56.2 ± 1.7
Phenylephrine dose (lg) 168 ± 3.2
Shivering (%) 13 (27%)
Intraoperative temperature (C)
10 min 34.3 ± 1.3
20 min 33.3 ± 1.4
30 min 32.1 ± 1.3
40 min 32.1 ± 2.1
50 min 32.6 ± 2.2
Rescue anti-shivering (%) 3 (6.25%)
Sedation score 0 (0–1)
Data are presented as mean ± standard deviation or number of patient
* P< 0.05 signiﬁcant compared with group M.To date, no studies discuss use of ephedrine as shivering
prophylaxis during CS under spinal anesthesia.
In this study, phenylephrine was used to keep blood pres-
sure within 10% from baseline value, so that the difference
in consumed phenylephrine (121 ± 2.2 in E group versus
168 ± 3.2 in M group, P value = 0.04) can be attributed to
use of ephedrine.
Limitations to this study include absence of a placebo con-
trol group as it would be non-ethical to include such a group to
identify the documented anti-shivering effect of the used drug.
Another limitation is that we did not record esophageal core
temperature as ephedrine was concluded, in a previous study
to prevent decrease of the core temperature during spineE group (n= 48) P value
T4 (T2–T5) 0.34
55.3 ± 2.2 0.6
121 ± 2.2* 0.04
14 (29%) 0.06
34.1 ± 1.2 0.52
32.5 ± 1.3 0.41
31.6 ± 1.4 0.43
31.3 ± 1.6 0.44
31.4 ± 1.9 0.45
4 (8.3%) 0.06
0 (0–0) 0.23
(percentage of study group) or median (range).
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cern of this study is to compare two anti-shivering drugs.
Further studies are needed to optimize the dose of ephed-
rine as shivering prophylaxis in women undergoing Cesarean
Section under spinal anesthesia.
In summary, a low dose ephedrine reduced the incidence
and intensity of shivering in women undergoing Cesarean Sec-
tion under spinal anesthesia as meperidine Moreover; it is
associated with less hypotension, nausea and vomiting and
comparable patient satisfaction.
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